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Synthesis and characterization of intermediate products
6-Chlorosalicylic acid
From 4.0 g 2-chloro-6-fluorobenzoic acid (22.9 mmol), 3.7 g NaOH (91.7 mmol) and 45 ml anhydrous DMSO as solvent (12 h, 130 °C). After cooling to room temperature, the reaction mixture was diluted with 100 ml water and acidified with 1M HCl (pH 1 
General procedure for the synthesis of chloroacetylsalicylic acids
1.0 g of chlorosalicylic acid (5.8 mmol) was dissolved in 20 ml of THF and added dropwise under cooling to a mixture of 20 ml of THF, 58 mmol acetic anhydride and 11.6 mmol of TEA. The mixture was stirred at room temperature until reaction was completed. 80 ml water was added and the reaction mixture was acidified with 1M HCl, then extracted three times with 50 ml of diethyl ether. Collected ether phases were washed with water and saturated NaCl solution and removed under reduced pressure. If necessary, product was purified with column chromatography prior to recrystallization. The product was recrystallized from toluene or a toluene-petroleum mixture.
3-Chloroacetylsalicylic acid (3-Cl-ASS)
Reaction time: 22.5 h; purification: recrystallization from petroleum/toluene (2:1); white solid; yield: 0.94 g (4.38 mmol, 76%); mp 122 °C.
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5-Chloroacetylsalicylic acid (5-Cl-ASS)
Reaction time: 3 h; purification: recrystallization from toluene; white solid; yield: 0.84 g (3.91 mmol, 68%); mp 142 °C. 
6-Chloroacetylsalicylic acid (6-Cl-ASS)
Reaction time: 20 h; purification: column chromatography using ethyl acetate/petroleum/glacial acetic acid (8:6:0.5), recrystallization from petroleum/toluene (2:1); white solid; yield: 0.92 g (4.29 mmol, 74%); mp 121 °C.
General procedure for the synthesis of chloroacetylsalicylic acid propargyl ester
The Cl-ASS derivative was dissolved in 10 ml anhydrous DCM. 0.2 equivalent DMAP and 1.1 equivalent propargyl alcohol were added under stirring, followed by the addition of 1.1 equivalent DCC under ice cooling. After 5 min of vigorous stirring, the ice bath was removed and reaction mixture was stirred at room temperature for 2 -3 h. A white precipitate was built (dicyclohexylurea, DCU), which was removed by filtration. The basic solvent was evaporated, the residue was dissolved in DCM und if necessary filtrated again. DCM phase was washed twice with 0.5M HCl and saturated NaHCO 3 solution, dried over NaSO 4 and evaporated under reduced pressure. As resulting yellowish oil is a mixture of the salicylic acid ester and the acetylsalicylic acid ester, acetylation was carried out again.
General procedure for the (re-)acetylation of chlorosalicylic acid propargyl ester
The (re-)acetylation was conducted analogously to the synthesis of chloroacetylsalicylic acids. Although, the starting material was a mixture of salicylic acid and acetylsalicylic acid ester, calculation of reaction mixture was calculated based on the pure chlorosalicylic acid ester. Workup was performed as described in the General procedure for the synthesis of chloroacetylsalicylic acids, except for the acidification before extraction which was not necessary. After removal of the solvent under reduced pressure, possibly generated DCU crystals were removed by filtration after dissolution in toluene. Toluene was removed under reduced pressure, a yellowish solid crystallizes, which was resuspended in petroleum. The product was collected on a frit and washed with petroleum.
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2-Acetoxy-3-chlorobenzoic acid prop-2-inyl ester (3-Cl-ASS propargyl ester)
From 0.70 g 3-chloroacetylsalcylic acid (3.26 mmol), 0.21 ml propargyl alcohol (3.59 mmol), 0.74 g DCC (3.59 mmol) and 0.08 g DMAP (0.65 mmol). White crystalline solid; yield: 0.59 g (2.34 mmol, 67%); mp 61 °C. 
2-Acetoxy-4-chlorobenzoic acid prop-2-inyl ester (4-Cl-ASS propargyl ester)
From 0.70 g 4-chloroacetylsalcylic acid (3.26 mmol), 0.21 ml propargyl alcohol (3.59 mmol), 0.74 g DCC (3.59 mmol) and 0.08 g DMAP (0.65 mmol). White crystalline solid; yield: 0.50 g (1.98 mmol, 51%); mp 49 °C. 25.4 ± 4.3 3-Cl-ASS 100 µM 27.0 ± 6.1 29.5 ± 3.5 n. t. 4-Cl-ASS 100 µM 60.2 ± 6.2 55.0 ± 2.7 n. t.
5-Cl-ASS 100 µM 56.4 ± 5.7 42.8 ± 0.4 n. t.
6-Cl-ASS 100 µM 30.0 ± 2.9 30.6 ± 3.2 n. t.
ASS-Propargyl 100 µM 25.4 ± 4.4 34.5 ± 4.2 n. t.
propargyl-3-Cl-ASS 100 µM 32.5 ± 1.9 52.2 ± 5.7 n. t.
propargyl-4-Cl-ASS 100 µM 24.0 ± 7.7 47.2 ± 5.3 n. t.
propargyl-5-Cl-ASS 100 µM 34.6 ± 0.5 52.0 ± 8.2 n. t.
propargyl-6-Cl-ASS 100 µM 37.3 ± 7.1 47.4 ± 6.0 n. t.
Co-ASS 10 µM 82.7 ± 3.2 78.5 ± 6.1 57.5 ± 3.0 3-Cl-Co-ASS 10 µM 24.9 ± 2.6 71.4 ± 8.3 37.7 ± 6.7
4-Cl-Co-ASS 10 µM 22.9 ± 1.7 69.9 ± 2.7 48.5 ± 6.8
5-Cl-Co-ASS 10 µM 25.0 ± 1.0 64.0 ± 7.5 41.9 ± 4.2 6-Cl-Co-ASS 10 µM 24.4 ± 3.0 70.5 ± 3.5 18.3 ± 1.9 
S7
